key: cord-0912176-kkcnp32g
authors: Hawks, Laura C.; Walker, Rebekah J.; Egede, Leonard E.
title: Individual and Combined Effect of Diabetes and Lifetime Criminal Justice Involvement on Healthcare Utilization in US Adults, 2015–2019
date: 2022-02-08
journal: J Gen Intern Med
DOI: 10.1007/s11606-021-07218-1
sha: 49b4f768d45c54bd40172b563ff4b4ef00bb1efd
doc_id: 912176
cord_uid: kkcnp32g

BACKGROUND: Diabetes and criminal justice involvement (CJI) are both associated with poor health outcomes and increased healthcare utilization. However, little is known about the additive effects of these risk factors when combined. This study examined the individual and combined effects of diabetes and CJI on healthcare utilization. METHODS: Data from the National Survey of Drug Use and Health (2015–2019) was used to create a cross-sectional, nationally representative sample of US adults with diabetes, CJI, combination of both, or neither. Negative binomial regression was used to test the association between those with CJI and diabetes (compared to diabetes alone) and three utilization types (outpatient, ED, and inpatient) controlling for relevant sociodemographic and clinical covariates. RESULTS: Of 212,079 respondents, representing 268,893,642 US adults, 8.8% report having diabetes alone, 15.2% report having CJI alone, and 1.8 % report both diabetes and lifetime CJI. After adjustment, those with diabetes and CJI had increased acute care utilization compared to those with diabetes alone (ED visits: IRR 1.13; 95% CI 1.00–1.28; nights hospitalized: IRR 1.34; 95% CI 1.08–1.67). There was no difference in outpatient utilization between those with both diabetes and CJI compared to those with diabetes alone (IRR 1.04, 95% CI 0.99–1.10). CONCLUSION: Individuals with complex social and health risks such as diabetes and lifetime CJI experience increased acute healthcare utilization but no difference in outpatient utilization. Tailored interventions that target both diabetes and CJI are needed to reduce unnecessary utilization in this population.

In the USA, diabetes mellitus (DM) is a significant contributor to morbidity and mortality, as well as a leading contributor to healthcare utilization and cost. 1 There are stark racial disparities in diabetes prevalence and outcomes, with Black Americans experiencing prevalence rates 40% greater than White Americans as well as increased risk of complications and death. 2 The COVID-19 pandemic has laid bare the preexisting health inequities imposed by structural racism, resulting in increased attention and burgeoning commitment to study the ways social risks layer onto health risks such that minority groups experience worse health outcomes for conditions such as diabetes. 3, 4 Criminal justice involvement (CJI) is a significant social risk factor for morbidity and mortality 5, 6 , and one experienced disproportionately by Black people in the USA. While Black American men constitute only 13% of the adult male population, they make up 40% of those incarcerated. 7 Those with CJI experience higher rates of infectious as well as noncommunicable disease, including an estimated 40% increased risk of diabetes. 8 Those returning to the community from prison or jail, and those under community supervision, experience higher mortality rates than their age-matched peers. 5, 9 Even limited exposure to the criminal justice system, such as being stopped by the police, is associated with worse overall well-being and deterioration in physical and mental health. 10 Examining the relationship between these overlapping risks faced disproportionately by minorities in the USA will be necessary to reduce disparities in health outcomes.

Prior work has examined the association between diabetes and healthcare utilization and CJI and healthcare utilization. 11, 12 Adults with diabetes, known to have higher rates of outpatient and acute care utilization, must engage with outpatient management to achieve diabetes control, thereby reducing risk of complications and overall healthcare costs. 13, 14 Those with CJI experience an increased likelihood of ED visits and hospitalization but decreased rates of outpatient utilization. [15] [16] [17] Increased acute care utilization may indicate poor disease control, especially among those with chronic illness. One way that CJI undermines health, especially in those with chronic disease, is by limiting access to employment (and thereby employer-sponsored insurance), which may decrease access to primary care. 18 Indeed, one study established an association between lower outpatient healthcare utilization and CJI but was not stratified by type of chronic disease. 19 It is possible that decreased access to preventive outpatient care may contribute to increased acute care utilization among those with CJI, particularly those with underlying diabetes.

However, little is known about the combined effects of CJI and diabetes on healthcare utilization. To better understand the individual and combined effects of diabetes and criminal justice involvement on outpatient or acute care utilization, this study used data from the National Survey of Drug Use and Health (NSDUH) to study the association between diabetes, lifetime CJI, neither, or both on utilization outcomes. We hypothesized that compared with diabetes alone, the combination of diabetes and criminal justice involvement would be associated with an additive increased rate of acute care utilization.

We used data from the NSDUH (2015-2019), the Substance Abuse and Mental Health Services Administration's (SAMHSA) annual, nationally representative, cross-sectional survey which provides annual epidemiologic data on the prevalence of substance use and mental health conditions and gathers substantial amounts of associated information, including some measures of chronic health and criminal justice involvement. While interviews are conducted in person, the majority of responses are provided directly into a computer. During the included study years, the response rate was 66-69%. 20 The survey is administered to participants aged 12 and older. We included in our sample all respondents aged 18 years and older.

To study the individual and combined effects of diabetes and lifetime CJI, we created four mutually exclusive categories to describe diabetes and lifetime CJI status:

1. Respondents with neither diabetes nor CJI, 2. Respondents with CJI and no diabetes (hereafter referred to as CJI alone), 3. Respondents with diabetes alone and no CJI (hereafter referred to as diabetes alone), 4. Respondents with both diabetes and CJI.

We identified respondents with lifetime CJI as those who responded "yes" to the question, "Not counting minor traffic violations, have you ever been arrested and booked for breaking the law? Being 'booked' means that you were taken into custody and processed by the police or by someone connected with the courts, even if you were then released." We identified respondents as having diabetes if they responded "yes" to the question, "Have you ever been told by a doctor or other healthcare professional that you have diabetes or sugar diabetes?"

Our dependent variables included three quantitative measures of outpatient, ED, and inpatient healthcare utilization during the prior 12 months. To assess the number of outpatient visits, we examined responses to the question: "During the past 12 months, how many times have you visited a doctor, nurse, physician assistant, or nurse practitioner about your own health at a doctor's office, a clinic, or some other place?" To assess the number of emergency department visits, we examined responses to the question: "During the past 12 months, how many different times have you been treated in an emergency room for any reason?" Finally, to measure nights of inpatient hospitalization, we examined responses to the question: "During the past 12 months, how many nights were you an inpatient in a hospital?"

A priori, we considered additional covariates based on identification of potential sociodemographic and clinical confounders. The following demographic covariates were used: age (categorized into 18-25, 26-34, 35-49 , and 50+ years); self-reported race/ethnicity (non-Hispanic white, non-Hispanic Black, Hispanic, other race/ethnicity [non-Hispanic Native American/Alaskan Native, non-Hispanic Native Hawaiian or Pacific Islander; non-Hispanic Asian; or more than one race]); self-reported gender (male, female); poverty level (<100% federal poverty level as determined by the Census Bureau, 100-200% poverty level, >200% poverty level); educational status (less than high school, high school degree or equivalent, some college, or college graduate); marital status (married, widowed/divorced/separated, never married); current employment status (full time, part time, unemployed, other [disabled, keeping house full-time; in school/training; retired; some other reason]); and insurance coverage (Medicare, Medicaid, VA healthcare, private, none).

Clinical covariates included a number of physical and mental health comorbidities. Physical comorbidities were identified by self-report, and included high blood pressure, heart condition, kidney disease, asthma, COPD, cirrhosis, hepatitis B/C, HIV/AIDS, and cancer. Mental health comorbidities included substance use disorder and mental illness. Both past year substance use disorder (SUD) and any mental health illness (AMI) were created using a validated series of questions within the dataset, which diagnostically predicts SUD or AMI. 21 Using DSM-IV criteria, the NSDUH model generates a diagnostic variable for substance abuse or dependence (now considered substance use disorder) including use of the following substances: alcohol, marijuana, cocaine, heroin, hallucinogens, inhalants, methamphetamine, pain relievers, tranquilizers, stimulants, or sedatives. 22 A similar NSDUH model uses a validated series of mental health questions to diagnostically predict presence of any mental illness. 23 Both were treated as a dichotomous variable in the analysis.

We first used Pearson's chi-square statistics to compare the sociodemographic characteristics and health profiles of our four groups of respondents. Secondly, we calculated the crude mean number (and 95% CI) of outpatient visits, ED visits, and nights hospitalized for each of the four groups. We then calculated unadjusted incident rate ratios (IRRs) using univariate negative binomial regression models for which the 4-category variable for diabetes and lifetime CJI status was the independent variable (those with diabetes alone serving as the reference group) and frequency of healthcare utilization was the dependent variable. Each utilization outcome (number of outpatient visits, ED visits, and nights hospitalized) was run as a separate model. Finally, multivariate negative binomial regression was used to calculate IRRs for the relationship between the 4-category diabetes and lifetime CJI status variable (those with diabetes alone again serving as the reference group) and three separate outcomes (number of outpatient visits, ED visits, and nights hospitalized). Models were adjusted for age, sex, race, poverty level, education, marital status, employment, health insurance coverage type, and comorbid medical, substance use, and mental health conditions.

We conducted all analyses with Stata version 16 (Stata Corp LP, College Station, TX) and used weights provided by SAMHSA that account for complex survey design and allow extrapolation for the US population as a whole. Survey weights were adjusted to account for combining multiple years of survey data in accordance with SAMHSA instructions (the final weight divided by the number of years of combined data; in this case, 5). We considered 2-sided p-values of less than 0.05 to be statistically significant.

The unweighted sample included 212,893 respondents, representing 268,983,642 US adults who participated in the most recent years (2015-2019) of the NSDUH. In this nationally representative sample, over a quarter of respondents reported at least one exposure: 8.8% diabetes alone, 15.2% CJI alone, and 1.8% diabetes and lifetime CJI. Demographic characteristics by diabetes and CJI status are displayed in Table 1 Table 3 reports the results of unadjusted and adjusted negative binomial regression models for healthcare utilization, in which diabetes alone served as the reference group. In models both unadjusted and fully adjusted for sociodemographic covariates and comorbid medical conditions, having both diabetes and prior CJI was associated with increased ED visits and night hospitalized, but not increased outpatient visits when compared to those having diabetes alone. Compared to those with diabetes alone, those with both diabetes and CJI experienced an IRR of 1.04 (95% CI 0.99-1.10) for outpatient utilization, an IRR of 1.13 (95% CI 1.00-1.28; p=0.04) for ED visits, and an IRR of 1.34 (95% CI 1.08-1.67) for inpatient nights. Those with neither diabetes nor CJI or CJI alone experienced a lower IRR for all three utilization categories when compared to those with diabetes alone. In these fully adjusted models, Black race was consistently strongly associated with higher rates of acute care utilization, as was lower socioeconomic status. The comorbid medical conditions most strongly associated with increased ED or inpatient utilization were heart condi- 

In this nationally representative sample, both lifetime criminal justice involvement and diabetes were common, with a quarter of respondents reporting at least one exposure.

Having both exposures was associated with higher rates of ED and inpatient visits relative to having diabetes alone in both unadjusted and fully adjusted models. However, there was no difference in outpatient utilization between these two groups. Similarly, those with CJI but not diabetes had higher rates of acute care utilization and no difference in outpatient utilization compared to those with neither exposure. Consistent with our hypothesis of overlapping social risks in this population, Black men and those of low socioeconomic status were overrepresented among those with both lifetime CJI and diabetes. Additionally, those with both diabetes and lifetime CJI reported high rates of comorbid heart disease, hypertension, COPD, substance use, and past-year mental illness. However, the additional risk of acute care utilization due to lifetime CJI among those with diabetes persisted in models adjusted for sociodemographic covariates and comorbid medical conditions. The medical literature has rarely attempted to evaluate the individual and cumulative effects that individuals exposed to multiple layers of social and health risks experience. To our knowledge, no prior studies have analyzed the additive effect of CJI and chronic disease, and this is the first study analyzing the individual or combined effects of diabetes and CJI on healthcare utilization. While it is well known that individuals with diabetes have higher rates of outpatient, ED, and inpatient utilization, and those with CJI have higher rates of ED and inpatient utilization 14, 15, 24 , our findings contextualize how CJI and diabetes function as combined risk factors for increased utilization of healthcare, especially acute care. The results show that individuals with either diabetes or CJI as a single risk factor are at higher risk of acute care utilization compared to those with neither. Moreover, there is an additive effect on acute care utilization when both risk factors occur simultaneously.

Our multivariate regression analyses highlighted other factors correlated with increased acute care utilization for those with both diabetes and CJI. In our fully adjusted model, comorbid heart disease, comorbid kidney disease, mental illness, and substance use disorder were independently associated with increased ED visits and hospitalization. Those with CJI have increased rates of cardiovascular disease, mental illness, and substance use disorder. 6, 25, 26 Studies suggest that both CJI and diabetes have a bidirectional causal relationship with mental illness. Mental illness increases risk for and is exacerbated by both CJI and diabetes and is associated with worse diabetes outcomes. 27, 28 Similarly, untreated substance use disorder has been shown to undermine glycemic control and is associated with increased likelihood of stroke, diabetic neuropathy, renal disease, and mortality in patients with diabetes. 29 Therefore, targeted interventions to treat these comorbidities may be crucial to achieving glycemic control and preventing unnecessary acute care utilization in patients with social risk factors.

Contrary to our hypothesis that those with CJI would experience decreased outpatient utilization, we found that those with CJI and diabetes had no difference in outpatient utilization compared to those with diabetes alone in unadjusted analyses. In the adjusted analyses, there was a small increase in utilization of marginal significance (IRR 1.04, 95% CI 0.99-1.10) for those with both exposures compared to those with diabetes alone. Taken in sum, the findings suggest that for those with diabetes, barriers to outpatient care alone cannot explain the relationship between CJI and increased acute care utilization. It is possible that those with CJI experience different quality of care due to structural barriers or access to different health systems 19 , although we are unable to further explore this question using NSDUH data.

Race/ethnicity is also strongly independently associated with increased acute care utilization-even after controlling for other indicators of socioeconomic status. These findings suggest the role of structural racism, a potentially modifiable risk factor, in the disparities identified in this study. 30, 31 Prior work has identified measures of socioeconomic status-both low income and low educationas indicators of increased acute care utilization among patients with diabetes 32,33 , but structural racism likely plays a role in how socioeconomic status influences racial/ ethnic disparities as well. For example, perceived intrapersonal discrimination has been generally linked with poor health outcomes in Black patients, which may influence acute care utilization. 34 Moreover, structural forces such as residential segregation, which leads to unique barriers to healthy food and transportation, may also contribute to increased acute care utilization, especially for patients with diabetes. 35 Identifying the numerous ways that structural racism impacts the healthcare outcomes of minorities in the USA is an important first step to reducing healthcare disparities. Based on these findings, developing interventions that target the combined social and health risks experienced by racial/ethnic minorities may be one way in which to move the field forward toward solutions. Our paper has several limitations worth noting. First, as a cross-sectional sample, our analyses cannot establish casual association. Secondly, because our data comes from a national survey, we are unable to distinguish different types or qualities of outpatient care. It is possible that those with CJI involvement receive more outpatient care that does not focus on diabetes management (such a primary care-based treatment for substance use disorder). Thirdly, criminal justice involvement and chronic medical conditions are self-reported, along with all other covariates. Prior research shows self-reported justice involvement tracks closely or better than administrative data 36 ; however, health conditions may be under-reported especially by those with less contact with the healthcare system. Finally, while healthcare utilization is a useful outcome in its own right, our research cannot comment on health outcomes due to the design of the survey. Future research should evaluate the role of healthcare utilization in clinical outcomes including glycosylated hemoglobin levels and rates of complications among those with diabetes and CJI compared to diabetes alone.

In conclusion, our study found that individuals with CJI and diabetes face compound layers of social and health risk, and those with both factors experience particularly high rates of acute care utilization. By identifying modifiable risk factors for those with CJI and diabetes, we can study meaningful interventions to reduce unnecessary healthcare utilization and increase regular engagement with the healthcare system.

Centers for Disease Control and Prevention, US Department of Health and Human Services Web site

Disparities in diabetes-related multiple chronic conditions and mortality: The influence of race

Structural racism, social risk factors, and Covid-19-a dangerous convergence for black Americans

This Time Must Be Different: Disparities During the COVID-19 Pandemic

Release from prison-a high risk of death for former inmates

The health and health care of US prisoners: results of a nationwide survey

Mass incarceration: The whole pie 2020. Prison Policy Initiative Web site

Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population

Age-Standardized Mortality of Persons on Probation

Exposure to the US Criminal Legal System and Well-Being: A 2018 Cross-Sectional Study

A high risk of hospitalization following release from correctional facilities in Medicare beneficiaries: a retrospective matched cohort study

Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes

Impact of primary care on hospital admission rates for diabetes patients: a systematic review. Diabetes research and clinical practice

Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes

Emergency department utilization among recently released prisoners: a retrospective cohort study

Increased hospital and emergency department utilization by individuals with recent criminal justice involvement: results of a national survey

Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization

Health and justice: framing incarceration as a social determinant of health for Black men in the United States

Health Status and Health Care Utilization of US Adults Under Probation

Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health: About the survey

National Survey on Drug Use and Health: Public Use File Codebook

Substance use disorders: diagnostic and statistical manual of mental disorders, (DSM-IV) and International Classification of Diseases, (ICD-10)

National Survey on Drug Use and Health: alternative statistical models to predict mental illness

Economic consequences of diabetes mellitus in the US in 1997

Cardiovascular Disease in Incarcerated Populations

Substance use disorders in prisoners: an updated systematic review and meta-regression analysis in recently incarcerated men and women

Beyond incarceration: Criminal justice contact and mental health

The relationship of depression and diabetes: Pathophysiological and treatment implications

Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings

Examining racism in health services research: A disciplinary self-critique

On racism: a new standard for publishing on racial health inequities

Association of socioeconomic status with diabetes prevalence and utilization of diabetes care services. BMC health services research

Relationship Between Avoidable Hospitalizations for Diabetes Mellitus and Income Level

Race, race-based discrimination, and health outcomes among African Americans

Trends in food insecurity in the United States from 2011-2017: Disparities by age, sex, race/ethnicity, and income. Population health management

Agreement between self-reported healthcare service use and administrative records in a longitudinal study of adults recently released from prison

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Corresponding Author Leonard E. Egede 

The dataset supporting the conclusions of this article are publicly available from the National Survey of Drug Use and Health website: https:// www. datafi les. samhsa. gov/ study-series/ natio nal-survey-drug-use-and-health-nsduh-nid13 517.The Medical College of Wisconsin's Institutional Review Board deemed this study exempt from review because the data are deidentified and publicly available.

The authors declare that they do not have a conflict of interest.